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Abstract 
Objective: To study the prevalence of peripheral neuropathy and evaluate the clinical nerve dysfunction in patients 
with chronic kidney disease. Study Design: Prospective study Place and duration: Medical ward Mayo hospital, 
Lady Wllingdon Hospital and Nishtar Hospital Multan from  March 2018 to  May 2019. Methodology: Eighty 
patients of clinically and biochemically proven chronic kidney disease were selected for study. Non probability 
consecutive sampling was used. Patients were assessed or both sensory and motor nerve dysfunction. SPSS 
software was used for data analysis. Main variables of study were creatinine clearance and neuropathy of peripheral 
nerves. Results: Affected patients percentage with reference to overt and subclinical neuropathy was noted as 
67.5%. Overt neuropathy and subclinical neuropathy observed as 35.2% and 64.8%, respectively. Patients affected 
with percentage with reference to the type of peripheral neuropathy were noted 67.5%. Sensory-motor, sensory 
and motor was observed as 31.5%, 14.8% and 53.7%, respectively. Conclusion: Peripheral neuropathy is highly 
associated with chronic kidney disease and severity and prevalence of neuropathy increases with worsening in 
renal failure. Early diagnosis and strict compliance required to overcome this condition. 
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Introduction 
Chronic kidney disease is associated with peripheral neuropathy1. Generally, patients would not come for 
examination of dysfunction of peripheral nerve supply until they looked for or asked for. Now in these days’ 
patients long term survival rate is improving because of latest advancement in medical treatment2. Recent 
improvement in CKD management with hemodialysis, peritoneal dialysis and transplant brought revolution. 
Lifespan of patients also improved due to latest treatment improvement3.  
It is essential to know about complications of CKD, if patients survive for long time, peripheral neuropathy 
is one of common complications of CKD4. Neuropathy in CKD is treatable. Signs and symptoms of CKD are in 
all cases but cases are different in nature5. Neuropathy is symmetrical, distal and mixed motor and sensory in 
nature affecting 65% CKD patients mostly lower limbs as compared to upper limb. Strict control on patient’s 
serum creatinine with on time dialysis and medical compliance reversal and progression of neuropathy is possible6. 
Peripheral neuropathy develops in male patients is greater than female and this difference is unexplained yet7. 
Intensity of disease and chronicity are main contributing features in peripheral neuropathy8. Existence of peripheral 
neuropathy clearly suspected and described in previous literature but metabolic disturbance of CKD and its 
dominated state of coma was not explained with its chronicity9,10. Many reports were conducted on this topic but 
no local study is available, so in this study incidence and severity of nerve dysfunction was assumed in CKD 
patients to fulfill the local reference gap. 
 
Methodology 
This prospective study was conducted at Medical ward Mayo hospital, Lady Wllingdon Hospital and Nishtar 
Hospital Multan from  March 2018 to  May 2019 after obtaining permission from hospital ethical board. Written 
consent was obtained from patients after detail information of study. Non probability consecutive sampling was 
used for data collection. Clinically and biochemically diagnosed cases of CKD were included in the study patients 
with serum creatinine >2mg, do not on dialysis and creatinine clearance < 40ml/mt were included. Patience with 
other contributing factors of peripheral neuropathy like diabetes was excluded from the study.  
Electrophysiological tests were performed for sensory and motor neuropathy. Median right ulnar, tibial nerve, 
common peronal and sural nerve supply was tested. All neurological and liver related findings were noted. SPSS 
version 23 was used for data analysis mean and SD was calculated for numerical values and frequencies 
(percentages) were calculated for qualitative data. P value less than or equal to 0.05 was taken as significant. 
 
Results 
Eighty patients were included in this study, both genders. Gender distribution revealed as n=54 (67.5%) males and 
n=26 (32.5%) females. (Figure. I). The mean duration of CKD was 3.87±1.89 years. The distribution of CKD 
verses peripheral nerve dysfunction was shown in table I.  
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Affected patients with percentage with reference to overt and subclinical neuropathy was noted as n=54 
(67.5%). While, overt neuropathy and subclinical neuropathy observed as n=19 (35.2%) and n=35 (64.8%), 
respectively.  Patients affected with percentage with reference to the type of peripheral neuropathy was noted n=54 
(67.5%). While, sensory-motor, sensory and motor were observed as n=17 (31.5%), n=8 (14.8%) and n=29 
(53.7%), respectively. (Table. II).  
The mean creatinine clearance 14.33±4.81 ml/mt. Distribution of male and female patients affected with 
reference to creatinine clearance was shown in table III.  
Table. I 
Distribution of peripheral nerve dysfunction in CKD patients versus duration of disease 
Duration of CKD (year) No. of patients with % Peripheral Nerve Dysfunction 
<1 n=17 (21.3%) n=13 (76.5%) 
1-3 n=28 (35%) n=19 (67.9%) 
3-5 n=20 (25%) n=14 (70%) 
>5 n=15 (18.8%) n=9 (60%) 
Total n=80 (100%) n=55 (68.8%) 
 
Table. II 
Variable N, (%) 
Patients affected with percentage with reference to overt and subclinical neuropathy 
Overt neuropathy n=19 (35.2%) 
Subclinical neuropathy n=35 (64.8%) 
Total n=54 (67.5%) 
Patients affected with percentage with reference to the type of peripheral neuropathy 
Sensory-motor n=17 (31.5%) 
Sensory n=8 (14.8%) 
Motor  n=29 (53.7%) 
Total n=54 (67.5%) 
 
Table. III 
Distribution of male and female patients affected with reference to creatinine clearance 
Creatinine clearance ml/mt Male Female 
<15 n=30 (75%) n=10 (25%) 
26-29 n=14 (60.9%) n=9 (39.1%) 
30-59 n=10 (58.8%) n=7 (41.2%) 
Total n=80 (100%) n=55 (68.8%) 
 
Figure. I 
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Discussion  
Common and recognized complication of CKD is peripheral neuropathy. It may lead to peripheral nervous system, 
morbidity and mortality. Renal derangement is the contributing factor of neuropathy11. In a study conducted by 
Sultan et al12 reported that renal derangement or CKD effect the nervous system. Peripheral neuropathy is the 
complication of CKD. 
In a study conducted by Kumar et al13 and concluded the involvement of CKD in disturbance of neurological 
system. Neuropathy is the main complication. He also reported that severity of disease has import on patient’s 
neurological condition. Sensory neuropathy was 34% and motor neuropathy was 16% observed. 
Babu et al14 conducted a study on this topic and focused on association of CKD and peripheral neuropathy. 
In that study impact of age was also observed on neuropathy and its severity. Age>65 years is more prove to 
peripheral neuropathy in CKD. Rathankumar et al15 completed a study in 2018 on peripheral dysfunction and CKD 
and conclude that distal sensory and motor neuropathy our two common types of peripheral neuropathy associated 
with CKD. In that study 64.8% of patients have peripheral neuropathy. Male patients with creatinine clearance 
having less that 15ml/mt are on greater risk. 
Another study was conducted by Arnold et al16 reported that CKD is highly associated with neurological 
complications which may lead to sourobidity and neutrality. May chronic neurological complications like stroke, 
dementia and cognitive impairment were also observed. 
In a study by Bolton et al17 observed similar findings and reported that a number of peripheral neurological 
disorders are associated with CKD. Cause behind this pathology is production of toxins in CKD. Renal 
transplantation is an option for its recovery. Another study was conducted by Nielsen et al18and concluded that 77% 
patients with CKD have peripheral neuropathy and remaining have signs of peripheral neuropathy. In that study 
slowing of nerve conduction was observed in patient with renal derangement since last 2 years. 
Aggarwal et al19 conducted a study on peripheral neuropathy in CKD patients and reported that sensory and 
motor neuropathies are associated with severity of disease or renal function; he observed symptomatic neuropathy 
in 51% of predialysis patients. Similar study was conducted by Krishnan et al20 in 2005 and reported 91% 
peripheral neuropathy in chronic kidney disease. This association was reported irreversible that cannot be reversed 
with early or delayed recovery from renal derangement. 
 
Conclusion 
Peripheral neuropathy is highly associated with chronic kidney disease and severity and prevalence of neuropathy 
increases with worsening in renal failure. Early diagnosis and strict compliance required to overcome this condition. 
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